Arrae MB-1 45+, Metabolic & Hormonal Wellness Support Dietary Supplement Capsules - 40ct

MB-1 45+ is a next-generation, natural supplement that’s designed to support metabolic and hormonal wellness throughout perimenopause, menopause and postmenopause. Built on the same foundation that made our original MB-1 formula a trusted favorite for over 1M+ women, MB-1 45+ has been rebuilt with clinically-studied, precision-targeted ingredients. MB-1 45+ doesn’t mask symptoms. It addresses the root causes by supporting the key hormones and metabolic pathways that shift throughout midlife—supporting appetite regulation, weight management, estrogen levels, and stress response with clinically-studied ingredients.* Directions: Take 2 MB-1 45+ capsules daily in the morning. Consistent use is recommended for at least 3 months to support best results.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not a treatment for obesity, type 2 diabetes or other metabolic diseases. This product is not intended for individuals 18 years old or under. This product is not intended for those pregnant, trying to become pregnant, or breastfeeding. MB-1 45+ has not been studied in combination with prescription medications or other supplements. If you have any concern about potential interactions, consult a medical professional before taking MB-1 45+. If you have any pre-existing health conditions, consult a medical professional before taking MB-1 45+. Transparent Third-Party Testing: Each individual ingredient is FTIR (Fourier Transform Infrared Spectroscopy) tested to confirm its identity and purity before formulation. All Arrae products undergo third party-testing (including heavy metal testing and a complete microbiological analysis), ensuring what’s on the label is exactly what’s in the bottle. Based on a 10 week randomized, double blind, placebo-controlled study on 102 overweight and/or obese participants taking IGOB131® published in Lipids in Health and Disease 2009. Based on an 8 week randomized, double blind, placebo-controlled study on 58 stressed healthy adult participants taking KSM-66® Ashwagandha published in Cureus 2019. *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.